WHO ICTRP trial
Study on reduction of skin autofluorescence (SAF) by various supplements
JPRN-UMIN000049951 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000049951 |
|---|---|
| Public title | Study on reduction of skin autofluorescence (SAF) by various supplements |
| Scientific title | Self-controlled, open-label, pre/post comparison study of functional supplements to characterize changes in SAF and study on population with reduced SAF - Research on individuals showing reduction of SAF by taking supplements |
| Primary sponsor | Okayama University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Advanced glycation end-products |
| Interventions | Hydrogen-releasing supplements for 20 weeks or Reduced form of CoQ10 for 20 weeks or Foods containing Salacia ingredients for 20 weeks or Foods containing mulberry leaf ingredients for 20 weeks or Foods containing mangosteen ingredients for… |
| Registration date | Jan 4, 2023 |
| Target size | 180 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: